Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Angiomed GmbH & Co. Medizintechnik KG is managing 4 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 4 distinct examiners and 3 distinct art units. ROBERTS, ANNA L is the busiest examiner, holding 1 busiest examiner pending action. This means each of the 4 distinct examiners is handling 1 of the 4 pending office actions.
The concentration in 3 distinct art units suggests technical overlap among the 4 pending office actions. With 4 distinct examiners involved, the company faces a diverse set of examiner-specific preferences. The 3 distinct art units indicate that the 4 pending office actions are spread across different technical groups. Since ROBERTS, ANNA L is the busiest examiner with 1 busiest examiner pending action, no single examiner dominates the current workload. This distribution of 4 pending office actions across 4 distinct examiners requires a broad prosecution strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, ANNA L | 1 | 56.7% | +38.5% |
| WOZNICKI, JACQUELINE | 1 | 49.8% | +26.0% |
| SHARMA, YASHITA | 1 | 81.8% | +24.6% |
| LABRANCHE, BROOKE N | 1 | 72.7% | +15.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18696245 | Implant and Method of Making an Implant | WOZNICKI, JACQUELINE | — |
| 18267742 | Stent Graft and Method of Making a Stent Graft | SHARMA, YASHITA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18032800 | System for Deploying an Implant | LABRANCHE, BROOKE N | 5d overdue |
| 18702229 | Implant | ROBERTS, ANNA L | — |
| 18696245 | Implant and Method of Making an Implant | WOZNICKI, JACQUELINE | — |
| 18267742 | Stent Graft and Method of Making a Stent Graft | SHARMA, YASHITA | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 3774 | 1 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18702229 | Implant | ROBERTS, ANNA L | 3791 | §103 | Final Rejection | — | Pending | Apr 17, 2024 |
| 18696245 | Implant and Method of Making an Implant | WOZNICKI, JACQUELINE | — | §103§112 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18267742 | Stent Graft and Method of Making a Stent Graft | SHARMA, YASHITA | 3774 | §102§103 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18032800 | System for Deploying an Implant | LABRANCHE, BROOKE N | 3771 | §103 | Non-Final OA | 5d overdue | Pending | Apr 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial